<DOC>
	<DOCNO>NCT01876329</DOCNO>
	<brief_summary>A review literature reveals study assess potential co-existence vitamin B12 deficiency due gastric parietal cell autoantibody . While Segal et al . 2004 publish study find 49 % patient RA vitamin B12 deficiency , assessment etiology presence autoantibody make . While Goeldner et al . 2011 Datta et al . 1990 demonstrate anti-gastric parietal cell antibody ( anti-GPC Ab ) find &lt; 5 % 28 % RA patient respectively , additional testing implement determine significance , specifically whether presence anti-GPC Ab relate vitamin B12 deficiency . The purpose study determine prevalence metabolic significance anti-GPC Ab three cohort : ( 1 ) group patient Rheumatoid Arthritis , ( 2 ) group patient autoimmune thyroid disease ( AITD ) , ( 3 ) group patient neither RA AITD . To determine significance presence anti-GPC Ab , test current serum B12 level along metabolite dependent adequate vitamin B12 level ( Methylmalonic acid ) test .</brief_summary>
	<brief_title>Autoantibodies Gastric Parietal Cells Rheumatoid Arthritis Patients</brief_title>
	<detailed_description>Background : Organ specific antibody anti-gastric parietal cell antibody ( anti-GPC Ab ) find variable number patient RA , unclear significance antibody actual vitamin B12 level . Patients RA find vitamin B12 deficiency near 50 % unclear deficiency due anti-GPC Ab . Hypothesis : By virtue aberrant autoimmune process occur RA , patient RA likely anti-GPC Ab likely control arm participant autoimmune thyroid disease ( AITD ) vitamin B12 deficiency . Method : 135 patient consent ; 45 RA arm , 45 AITD arm , 45 control arm . Exclusion criterion filter patient would reason alter vitamin B12 absorption , inflammatory bowel disease , surgery , medication use . After obtain consent subject send lab serum anti-GPC Ab test ( obtainable SLE panel ) , RF , B12/folate ( available order CHCS ) , methyl malonic acid , ( control arm subject AITD subject ) anti-CCP IgG . Patients also complete one-sided , one page questionnaire ask dietary medication exposure . Outcomes : ( 1 ) Determine whether evidence serum vitamin B12 deficiency , measure either low vitamin B12 level elevate methylmalonic acid , common RA patient anti-GPC Ab . ( 2 ) Determine prevalence anti-GPC Ab group patient RA compare group patient AITD know systemic organ specific autoimmune condition .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Vitamin B 12 Deficiency</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Autoantibodies</mesh_term>
	<criteria>Adult , age 18 old RA arm : History Rheumatoid Arthritis AITD arm : History autoimmune thyroid disease without history clinically obvious manifestation organ specific systemic autoimmune process . Control arm : No history RA history clinically obvious manifestation organ specific systemic autoimmune process . Known vitamin B12 deficiency participant formerly treat continue receive therapy . Active malabsorptive state include limited celiac disease , inflammatory bowel disease , etc . Surgically induced malabsorptive state include limited RouxenY Gastric bypass Use medication may interfere vitamin B12 absorption Patients thyroid condition consistent autoantibody process ( i.e . congenital absence thyroid , infectious thyroiditis , thyroidectomy nonautoimmune process , toxic multinodular goiter ) exclude autoimmune thyroid arm .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Vitamin B12 deficiency</keyword>
	<keyword>Autoimmune Thyroid Disease</keyword>
	<keyword>Autoantibodies</keyword>
</DOC>